Author Of 2 Presentations
P0121 - Objective measurement of speech correlates with disease status and quality of life in people with MS without dysarthria (ID 1681)
Abstract
Background
Objective measurement of speech has shown promising results to monitor disease state in Multiple Sclerosis (MS). Yet, it is not clear if changes in speech can be detected before overt dysarthria.
Objectives
In this study, we characterize the relationship between disease severity and objective speech metrics exclusively in people with no perceivable dysarthria.
Methods
An acoustic composite score was calculated using regression modelling of speech data from 119 people with MS (pwMS, 75% female), irrespective of dysarthria presence. That score was then tested in pwMS without dysarthria, as determined by blinded perceptual rating, for correlations with the Expanded Disability Status Scale (EDSS), brain volume and lesion load from magnetic resonance imaging, and quality of life scores from the Multiple Sclerosis Impact Scale (MSIS-29) .
Results
PwMS without dysarthria (n=77) were more likely to be female (82% vs 62%, p=0.017), were on average 5.7 years younger (age mean ± standard deviation 53.5±11.4, p=0.009), had MS for 2.5 years shorter (11±8.5 years, p=0.034) and scored EDSS 1.7 step lower (2.7±1.9, p<0.001) than pwMS with dysarthria (n=42). The acoustic composite score correlated with EDSS scores (r=0.45, p<0.001) and quality of life (r=0.4, p=0.01) in pwMS without perceivable dysarthria, but not with brain volume or lesion load.
Conclusions
Acoustic analysis offers a valuable insight into the subclinical development of speech impairment in MS. These results highlight the potential of automated analysis of speech to assist in monitoring disease progression and treatment response.
P0572 - Evaluation of cerebellar function scores in relation to cerebellar axonal loss in multiple sclerosis. (ID 933)
Abstract
Background
Damage to the cerebellum is common in people with multiple sclerosis (pwMS) and associated with a worse prognosis and, cerebellar relapses are associated with poorer recovery and earlier onset of progressive disease. Studies examining the importance of the cerebellum are hampered by incomplete characterisation of cerebellar damage and its relation to cerebellar function.
Objectives
We aim to examine axonal loss in the cerebellum using diffusion imaging and compare the degree of cerebellar axonal loss with cerebellar dysfunction in pwMS.
Methods
We prospectively recruited 55 pwMS and 14 healthy controls (HC). Clinical assessments included scale for the assessment and rating of ataxia (SARA) and Bain tremor ratings. Subjects underwent 3-tesla volumetric, lesion and diffusion magnetic resonance imaging. Cerebellar axonal loss was examined with fibre-specific markers. Fibre density and cross-section (FDC) accounts for microscopic and macroscopic changes in a fibre bundle.
Results
Significant loss of cerebellar FDC was found in pwMS compared to HC (p=0.03). Lower FDC was associated with increased SARA (r=-0.42, p<0.01) and tremor severity (rho=-0.35, p=0.01). Cerebellar lesion volume correlated with SARA (r=0.49, p<0.01) and tremor severity (rho=0.41, p=0.01). Cerebellar volume showed no correlation with cerebellar clinical assessments.
Conclusions
Fibre-specific measures of cerebellar pathology could provide a functionally relevant marker of cerebellar damage in pwMS. Future trials using fibre-specific markers are needed to further characterise cerebellar pathology and understand its significance in disease progression.